DMYD B — Diamyd Medical AB Balance Sheet
0.000.00%
- SEK156.53m
- -SEK93.80m
- SEK0.48m
Annual balance sheet for Diamyd Medical AB, fiscal year end - August 31st, SEK millions except per share, conversion factor applied.
2022 August 31st | 2023 August 31st | 2024 August 31st | 2025 August 31st | 2026 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Preliminary |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 160 | 128 | 132 | 277 | 305 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.44 | 4.67 | 4.02 | 4.64 | 2.71 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 173 | 141 | 159 | 292 | 309 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 45.7 | 52.3 | 49.4 | 52.7 | 46.6 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 237 | 206 | 217 | 353 | 365 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 21.4 | 19.9 | 40 | 27.5 | 34.1 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 22.1 | 36.4 | 71.1 | 72.6 | 122 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 214 | 169 | 146 | 280 | 244 |
| Total Liabilities & Shareholders' Equity | 237 | 206 | 217 | 353 | 365 |
| Total Common Shares Outstanding |